Leadsynbio was recently featured on Suzhou News. The segment will take you inside our biomanufacturing lab, offering a firsthand look at our development and deployment of synthetic biology.

Recently, Leadsynbio’s microbially fermentation-based β-nicotinamide mononucleotide (NMN) reached another core U.S. market compliance milestone, officially receiving a New Dietary Ingredient (NDI) No Objecti...
[ Details ]Nov 16,2026